Clinical inputs
Understand the result,
not just the number.
EVEREST HF Prognostic Algorithm — explanation and context The EVEREST score is a 0–18 clinician-rated composite of six symptoms/signs of congestion: dyspnea, orthopnea, fatigue, jugular venous distension (JVD), rales, and pedal edema. Each item is graded 0–3 using the standardized EVEREST grading scale (0 = none; 1 = seldom or mild; 2 = moderate/frequent; 3 = continuous/marked or the numeric JVD/rales/edema thresholds defined in the original paper). The score was developed from the EVEREST trial dataset and has been used in post-hoc analyses to quantify residual clinical congestion at discharge.
In published work a discharge EVEREST score < 2 has been proposed as a practical decongestion target; even small increases (for example ≥1) have been associated with higher subsequent risk of heart-failure events and rehospitalization, and higher scores (for example ≥3) with higher mortality risk over months. This tool reproduces the original EVEREST grading approach to provide a consistent, reproducible clinician-rated congestion score for bedside use.
- Source 1
Andrew P. Ambrosy et al., “Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.” Eur Heart J. 2013;34:835–843. Nadia Bouabdallaoui et al., “Assessing Splanchnic Compartment Using Portal Venous Doppler and Impact of Adding It to the EVEREST Score for Risk Assessment in Heart Failure.” (Can J Cardiol) 2020 — description and validation context of the EVEREST score. Integrative reviews and guideline summaries describing EVEREST score use and interpretation.
Loading discussion…